To explore new therapeutic approaches to improve cognitive impairment or dementia, we examined the possible ameliorative role of AT2 receptor activation in cognition in our mouse model by employing mice with AT2 receptor overexpression in vascular smooth muscle cells (VSMC). The gene discussed is AGTR2; the disease is Cognitive impairment.